Tirosint Solution
Product Images NDC 71858-0150

21 FDA label images from Ibsa Pharma Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Tirosint (NDC 71858-0150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ibsa Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tirosint 01)

Chemical Structure (Tirosint 01)
Chemical structure of Levothyroxine Sodium, showing the molecular arrangement including iodinated aromatic rings, an ether linkage, and a sodium carboxylate group with hydration.*
FDA Label Image

Figure A (Tirosint 07)

Figure A (Tirosint 07)
An instructional illustration showing a pair of scissors cutting open a rectangular packet or sachet held by a hand. The image suggests how to open a single-use packet, likely related to the administration of the oral solution.*
FDA Label Image

Figure B (Tirosint 03)

Figure B (Tirosint 03)
An instructional illustration showing a person holding and separating individual plastic ampules from a strip, demonstrating how to open single-dose ampules used for oral solution administration.*
FDA Label Image

Figure C (Tirosint 04)

Figure C (Tirosint 04)
An instructional diagram showing hands removing or attaching the cap of a small bottle or container. The illustration conveys the proper method to open or close the bottle securely, as part of product usage directions.*
FDA Label Image

Figure D (Tirosint 05)

Figure D (Tirosint 05)
An instructional illustration showing a hand holding a dropper with a liquid dose above a cup of water, demonstrating how to add the liquid medication to the water for oral administration.*
FDA Label Image

Figure E (Tirosint 06)

Figure E (Tirosint 06)
An instructional line drawing depicting a hand holding an oral dropper bottle positioned near an open mouth, illustrating the method for administering oral liquid medication.*
FDA Label Image

13 Mcg (As Tirosintsol Trade 13)

13 Mcg (As Tirosintsol Trade 13)
Packaging label for Tirosint SOL, containing levothyroxine sodium oral solution at a strength of 13 microgram/mL. The label indicates a package size of 6 pouches with 5 ampules each. The labeler is IBSA Pharma Inc. The box includes warnings for oral use only and not for inhalation, injection, or ophthalmic use. Additional manufacturer and distributor information is provided, listing IBSA Institut Biochimique SA in Switzerland as the manufacturer and IBSA Pharma Inc. in New Jersey as the distributor.*
FDA Label Image

25 Mcg/ml (As Tirosintsol Trade 25)

25 Mcg/ml (As Tirosintsol Trade 25)
Packaging label for Tirosint SOL oral solution with 25 microgram/mL levothyroxine sodium. The package contains 6 pouches, each with 5 ampules. Label includes warnings for oral use only, manufacturer IBSA Pharma Inc., and distribution details. The label also features storage instructions and tamper-evident information.*
FDA Label Image

37.5 Mcg/ml (As Tirosintsol Trade 37.5)

37.5 Mcg/ml (As Tirosintsol Trade 37.5)
Packaging label for Tirosint SOL oral solution containing levothyroxine sodium at 37.5 microgram/mL strength. The label indicates the product is available as 6 pouches with 5 ampules each. It is for oral use only, distributed by IBSA Pharma Inc., and manufactured in Germany.*
FDA Label Image

44 Mcg/ml (As Tirosintsol Trade 44)

44 Mcg/ml (As Tirosintsol Trade 44)
Packaging label for Tirosint SOL 44 microgram/mL oral solution containing levothyroxine sodium. The carton indicates a total of 6 pouches each containing 5 ampules. The label states the solution is for oral use only, not for inhalation, injection, or ophthalmic use. Manufactured for IBSA Pharma Inc., with contact information and barcode visible on the label.*
FDA Label Image

50 Mcg/ml (As Tirosintsol Trade 50)

50 Mcg/ml (As Tirosintsol Trade 50)
Tirosint SOL 50 microgram/mL (levothyroxine sodium) oral solution packaging label showing a carton for 6 pouches each containing 5 ampules. The label includes usage instructions indicating the product is for oral use only and Rx only. It is manufactured for IBSA Pharma Inc. and distributed by IBSA Pharma Inc., Parsippany, NJ, made in Germany. The packaging includes storage, dosage, and tamper-evident information along with the IBSA logo.*
FDA Label Image

62.6 Mcg/ml (As Tirosintsol Trade 62.5)

62.6 Mcg/ml (As Tirosintsol Trade 62.5)
Packaging label for Tirosint SOL levothyroxine sodium oral solution at 62.5 microgram/mL strength. The label indicates a package containing 6 pouches with 5 ampules each, manufactured for IBSA Pharma Inc. The label includes usage directions stating it is for oral use only, not for inhalation, injection, or ophthalmic use. The product is distributed by IBSA Pharma Inc. in New Jersey and made in Germany.*
FDA Label Image

75 Mcg/ml (As Tirosintsol Trade 75)

75 Mcg/ml (As Tirosintsol Trade 75)
Packaging label for Tirosint SOL oral solution containing levothyroxine sodium at a strength of 75 microgram/mL. The product comes in a package of 6 pouches with 5 ampules each. It is labeled for oral use only and is manufactured by IBSA Pharma Inc., with manufacturing in Switzerland and distribution in Parsippany, NJ. The label includes usage and storage instructions and a prominent IBSA logo.*
FDA Label Image

88 Mcg/ml (As Tirosintsol Trade 88)

88 Mcg/ml (As Tirosintsol Trade 88)
The packaging label for Tirosint SOL levothyroxine sodium oral solution displays a concentration of 88 microgram/mL. The label indicates a package containing 6 pouches each with 5 ampules. The label includes usage instructions emphasizing oral use only, not for inhalation, injection, or ophthalmic use. Manufactured for IBSA Pharma Inc., with manufacturing details from Switzerland and distribution from Parsippany, NJ.*
FDA Label Image

100 Mcg/ml (As Tirosintsol Trade 100)

100 Mcg/ml (As Tirosintsol Trade 100)
Packaging label for Tirosint SOL (levothyroxine sodium) oral solution with strength 100 microgram/mL. The box indicates it contains 6 pouches, each with 5 ampules. The label states the product is for oral use only and is Rx only. Manufactured for IBSA Pharma Inc., made in Germany, with distribution information listed. The packaging features the IBSA logo and includes use and storage instructions.*
FDA Label Image

112 Mcg/ml (As Tirosintsol Trade 112)

112 Mcg/ml (As Tirosintsol Trade 112)
Packaging label for Tirosint SOL 112 microgram/mL oral solution containing levothyroxine sodium. The label shows a box design with the dosage strength prominently highlighted, indicating 6 pouches each containing 5 ampules. The product is distributed by IBSA Pharma Inc. and manufactured by IBSA Institut Biochimique SA in Switzerland, made in Germany. The label emphasizes oral use only and includes storage and usage information.*
FDA Label Image

125 Mcg/ml (As Tirosintsol Trade 125)

125 Mcg/ml (As Tirosintsol Trade 125)
Packaging label for Tirosint SOL, levothyroxine sodium oral solution at 125 microgram/mL strength. The carton contains 6 pouches with 5 ampules each. Manufactured for IBSA Pharma Inc. and distributed by IBSA Pharma Inc., Parsippany, NJ. Marked Rx only and for oral use only, not for inhalation, injection, or ophthalmic use.*
FDA Label Image

137 Mcg/ml (As Tirosintsol Trade 137)

137 Mcg/ml (As Tirosintsol Trade 137)
Packaging label for Tirosint SOL oral solution containing levothyroxine sodium at a strength of 137 microgram/mL. The box indicates it contains 6 pouches with 5 ampules each. Labeler information shows IBSA Pharma Inc., with manufacturing in Germany. The label highlights that the product is for oral use only and is prescription only (Rx Only).*
FDA Label Image

150 Mcg/ml (As Tirosintsol Trade 150)

150 Mcg/ml (As Tirosintsol Trade 150)
Packaging label for Tirosint SOL Oral Solution containing Levothyroxine Sodium at a strength of 150 microgram/mL. The box indicates the product is for oral use only and comes in a package of 6 pouches each containing 5 ampules. Manufactured for IBSA Pharma Inc. and made in Germany. The label includes usage directions, storage conditions, and tamper-evident warnings.*
FDA Label Image

175 Mcg/ml (As Tirosintsol Trade 175)

175 Mcg/ml (As Tirosintsol Trade 175)
Packaging label for Tirosint SOL 175 microgram/mL (levothyroxine sodium) oral solution. The label indicates it is for oral use only, not for inhalation, injection, or ophthalmic use. The package contains 6 pouches with 5 ampules each and is distributed by IBSA Pharma Inc. The label includes storage instructions and a tamper-evident warning.*
FDA Label Image

200 Mcg/ml (As Tirosintsol Trade 200)

200 Mcg/ml (As Tirosintsol Trade 200)
Packaging label for Tirosint SOL 200 microgram/mL oral solution containing levothyroxine sodium. The label indicates the product is for oral use only, not for inhalation, injection, or ophthalmic use. It includes 6 pouches with 5 ampules each and is produced by IBSA Pharma Inc. The packaging also provides storage instructions, tamper-evident warnings, and is marked for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.